Cargando…

Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma

BACKGROUND: Src, an oncoprotein that drives progression of head and neck squamous cell carcinoma (HNSCC), is commonly hyperactivated in this disease. Unfortunately, the clinical benefit of targeting Src is significantly dampened in HNSCC patients, because the cytotoxic effects of anti-Src therapy an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Liwei, Shay, Chloe, Zhao, Xiangdong, Xiong, Yuanping, Wang, Xuli, Teng, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896687/ https://www.ncbi.nlm.nih.gov/pubmed/31805962 http://dx.doi.org/10.1186/s13045-019-0827-1

Ejemplares similares

Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
por: Lang, Liwei, et al.
Publicado: (2018)

Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib
por: Lang, Liwei, et al.
Publicado: (2020)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
por: Du, Guifang, et al.
Publicado: (2020)

An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain
por: Danson, Sarah, et al.
Publicado: (2019)

Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle
por: Zhang, Yongjun, et al.
Publicado: (2009)

The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer
por: Arcaroli, John, et al.
Publicado: (2012)

The effects of Src tyrosine kinase inhibitor, saracatinib, on the markers of epileptogenesis in a mixed-sex cohort of adult rats in the kainic acid model of epilepsy
por: Rao, Nikhil S., et al.
Publicado: (2023)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity
por: Teng, Yong, et al.
Publicado: (2017)

Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy
por: Sharma, Shaunik, et al.
Publicado: (2021)

Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study
por: Oswald, Ailsa J., et al.
Publicado: (2023)

FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis
por: Lang, Liwei, et al.
Publicado: (2021)

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway
por: Yang, Zejia, et al.
Publicado: (2019)

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
por: Huang, R Y-J, et al.
Publicado: (2013)

Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress
por: Gage, Meghan, et al.
Publicado: (2021)

Intracellular reduction in ATP levels contributes to CYT997‐induced suppression of metastasis of head and neck squamous carcinoma
por: Zhao, Xiangdong, et al.
Publicado: (2018)

Crosstalk between Activated and Inactivated c-Src in Hepatocellular Carcinoma
por: Chen, Mei-Lin, et al.
Publicado: (2011)

“The emerging role of capivasertib in breast cancer”
por: Andrikopoulou, Angeliki, et al.
Publicado: (2022)

The Prognostic Significance of Src and p-Src Expression in Patients with Osteosarcoma
por: Hu, Chao, et al.
Publicado: (2015)

Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis
por: He, Leilei, et al.
Publicado: (2019)

Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar
por: Su, Linlin, et al.
Publicado: (2016)

Akt and Src mediate the photocrosslinked fibroin-induced neural differentiation.
por: Moysenovich, Anastasia M., et al.
Publicado: (2020)

The potential of Src inhibitors
por: Elias, Daniel, et al.
Publicado: (2015)

Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis
por: Hartig, Sean M., et al.
Publicado: (2011)

Structural and functional characterization of the divergent Entamoeba Src using Src inhibitor-1
por: López-Contreras, Luilli, et al.
Publicado: (2017)

The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling
por: Ichikawa-Tomikawa, Naoki, et al.
Publicado: (2023)

Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas
por: Veracini, Laurence, et al.
Publicado: (2014)

c-src structure in human cancers with elevated pp60c-src activity.
por: Wang, P., et al.
Publicado: (1991)

Immunolocalization of the cellular src protein in interphase and mitotic NIH c-src overexpresser cells
Publicado: (1990)

v-Src-driven transformation is due to chromosome abnormalities but not Src-mediated growth signaling
por: Honda, Takuya, et al.
Publicado: (2018)

Molecular docking analysis of beta-caryophyllene with IRS-1, cSrc and Akt
por: Mani, Vadivel, et al.
Publicado: (2021)

Insertion Device Commmissioning at SRC
por: Green, M A, et al.
Publicado: (2001)

Src: coordinating metabolism in cancer
por: Pelaz, Sara G., et al.
Publicado: (2022)

Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors
por: Egloff, Ann Marie, et al.
Publicado: (2009)

Src-mediated caveolin-1 phosphorylation affects the targeting of active Src to specific membrane sites
por: Gottlieb-Abraham, Efrat, et al.
Publicado: (2013)

CTSA Consortium Consensus Scientific Review Committee (SRC) Working Group Report on the SRC Processes
por: Selker, Harry P., et al.
Publicado: (2015)

C-terminal Src kinase (Csk) regulates the tricellular junction protein Gliotactin independent of Src
por: Samarasekera, G. D. N. Gayathri, et al.
Publicado: (2018)

Implications of the Estrogen Receptor Coactivators SRC1 and SRC2 in the Biological Basis of Gender Incongruence
por: Ramírez, Karla del Valle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l96nc5nbt9dum6v5rh47sl1319